Article
The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
The Journal of clinical endocrinology and metabolism - 1 Nov 2011
Derr Michael A, Aisenberg Javier, Fang Peng, Tenenbaum-Rakover Yardena, Rosenfeld Ron G, Hwa Vivian
Abstract excerpt
CONTEXT: GH insensitivity (GHI) is a condition characterized by pronounced IGF-I deficiency and severe short stature. We previously identified a novel compound heterozygous GH receptor (GHR) mutation, GHR:p.R229H/c.899dupC, in a patient presenting with GHI. The heterozygous p.R229H (prepeptide) variant was previously associated with GHI despite a lack of adequate functional studies. The novel heterozygous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
